John Henderson
Chairman at CYTOKINETICS, INCORPORATED
Net worth: 2 M $ as of 2024-04-29
John Henderson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Independent Dir/Board Member | 2011-10-30 | - |
| Chairman | 2022-04-07 | - | |
| Director/Board Member | 2009-01-31 | 2022-04-07 |
Career history of John Henderson
Former positions of John Henderson
| Companies | Position | Start | End |
|---|---|---|---|
| MYRIAD GENETICS, INC. | Director/Board Member | 2020-03-22 | 2020-12-03 |
| Chairman | 2005-03-31 | 2020-03-22 | |
| Independent Dir/Board Member | 2004-04-30 | 2020-12-03 | |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | 2018-09-30 |
| MYREXIS, INC. | Director/Board Member | 2009-12-01 | 2012-12-31 |
| Independent Dir/Board Member | 2009-02-18 | 2012-12-31 | |
| PFIZER, INC. | Corporate Officer/Principal | - | 2010-11-30 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | - | 2000-11-30 |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Chairman | 2009-03-31 | - |
| Futurepharm LLC | President | 2000-11-30 | - |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Director/Board Member | - | - |
Training of John Henderson
| The University of Edinburgh | Doctorate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 2 |
| Canada | 2 |
Operational
| Director/Board Member | 4 |
| Chairman | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 7 |
| Commercial Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| MYREXIS, INC. | Finance |
| Private companies | 5 |
|---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
| Futurepharm LLC | |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John Henderson
- Experience
